Whistleblower News from the Inside - September 12, 2014

By the C|C Whistleblower Lawyer Team

Bipartisan support for strengthening whistleblower protections — “To say it was heartwarming would be a stretch, but it was good to see the bipartisan support this week on behalf of federal whistleblowers from a congressional panel” with many seeming “pretty disgusted with the way Uncle Sam can treat federal employees who report waste, fraud and abuse.”  Washington Post

Highlights from House hearing on whistleblower treatment —  Representatives at Tuesday’s House subcommittee hearing on whistleblower retaliation in the federal government expressed support for additional legislation to address unresolved issues from the Whistleblower Protection Enhancement Act (WPEA).  GAP

Patent Office whistleblowers’ formal complaints revealed — The Washington Post has published the internal complaints of government workers alleging widespread fraud at the agency.  Washington Post

Summertime developments in Dodd-Frank — Forbes examines hot topics under Dodd-Frank including an award to a compliance employee whistleblower and recent cases that dodged the issue of whether whistleblowers are protected under Dodd-Frank if they only report internally and not to the SEC.  Forbes

Directors Could Be Personally Liable for Off-Label Drug Marketing Violations — A recent decision of the Ninth Circuit Court of Appeals indicates that corporate directors could face personal liability for off-label drug marketing penalties.  Huffington Post

Whistleblower says VA appeals board manipulated records — A VA whistleblower testified before Congress that agency managers handling disability benefit appeals have manipulated records to conceal delays in deciding cases.  Stars & Stripes